HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia

HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia

Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom’s macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal to...

Full description

Bibliographic Details
Main Author:	Mark R. Wallace
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Case Reports in Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/2020/6516037

Similar Items

Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia
by: Papanota AM, et al.
Published: (2019-08-01)

Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
by: Andrea Aiello, et al.
Published: (2017-01-01)

Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia
by: Anantha Sriharsha Madgula, MBBS, et al.
Published: (2020-09-01)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
by: María Poza, et al.
Published: (2021-08-01)

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia
by: Branagan, A.R, et al.
Published: (2022)

Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenström Macroglobulinemia on and off Clinical Trials
by: Jorge J. Castillo, et al.
Published: (2020-06-01)

Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy
by: Branagan, A.R, et al.
Published: (2022)

Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib
by: Hassaan Jafri MD, et al.
Published: (2021-06-01)

Pseudohyperphosphatemia in Waldenstrom′s Macroglobulinemia
by: S D Amalnath, et al.
Published: (2013-01-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

Diagnóstico presuntivo de la macroglobulinemia de Waldenström Presumptive diagnosis of the macroglobulinemia of Waldenström
by: Ana Dolores Izquierdo Calzado
Published: (2012-04-01)

Cutaneous macroglobulinosis with Waldenström macroglobulinemia
by: Hussein M.M. Hassab-El-Naby, MD, et al.
Published: (2020-08-01)

Waldenström's macroglobulinemia - a review
by: Susana Coimbra, et al.
Published: (2014-10-01)

Unusual presentation of Waldenstrom macroglobulinemia
by: Chih-Yu Chang, et al.
Published: (2018-03-01)

Venetoclax in Previously Treated Waldenström Macroglobulinemia
by: Advani, R.H, et al.
Published: (2022)

Focal Segmental Glomerulosclerosis in Waldenström’s Macroglobulinemia
by: Akshee Batra, et al.
Published: (2020-01-01)

Waldenstrom's Macroglobulinemia: A case report
by: Nejima Kolikkat, et al.
Published: (2020-01-01)

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
by: Wei Zhou, et al.
Published: (2012-04-01)

CNS Vasculitis Associated with Waldenström Macroglobulinemia
by: Tanawan Riangwiwat, et al.
Published: (2016-01-01)

Updates in prognostication and treatment of Waldenström’s macroglobulinemia
by: Pooja Advani, et al.
Published: (2019-12-01)

Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
by: Kratochvil David, et al.
Published: (2012-12-01)

Pseudovitelliform Subfoveal Deposit in Waldenström’s Macroglobulinemia
by: Aurélie Brolly, et al.
Published: (2012-08-01)

Cardiac amyloidosis secondary to waldenström macroglobulinemia
by: Lachira-Yparraguirre, Lizbeth, et al.
Published: (2021)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis
by: Shinta Oktya Wardhani, et al.
Published: (2016-11-01)

Current and novel BTK inhibitors in Waldenström’s macroglobulinemia
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2021-02-01)

MACROGLOBULINEMIA DE WALDENSTROM: ESTUDO DE CASO
by: C.A.S. Souza, et al.
Published: (2020-11-01)

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
by: Rana Rafiei, et al.
Published: (2020-05-01)

Severe Acidemia in a Patient With Waldenström Macroglobulinemia
by: Judy Hindi, et al.
Published: (2020-09-01)

Renal MALT lymphoma associated with Waldenström macroglobulinemia
by: Po-Jui Chi, et al.
Published: (2014-04-01)

Localized retinal degeneration secondary to Waldenström's macroglobulinemia
by: Dhanashree Ratra, et al.
Published: (2017-01-01)

Waldenstrom macroglobulinemia involving the superior rectus muscle
by: J.B. Hellman, et al.
Published: (2018-06-01)

Sign of Leser-Trélat Associated with Waldenström's Macroglobulinemia
by: Kozo Yoneda, et al.
Published: (2021-01-01)

Severe nephritis as initial sign of Waldenström’s macroglobulinemia
by: Thomas Knoop, et al.
Published: (2019-12-01)

Macroglobulinemia de Waldenström com hemorragia intra-ocular Waldenström's macroglobulinaemia with intraocular hemorrhage
by: João J. Nassaralla Júnior, et al.
Published: (2006-12-01)

Infiltración orbitaria en la macroglobulinemia de Waldenström
by: Felipe Costales-Mier, et al.
Published: (2016-03-01)

Waldenstrom's macroglobulinemia: An unusual cause of nonhealing leg ulcers
by: Navjyot Kaur, et al.
Published: (2017-01-01)

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology
by: Maiso Patricia, et al.
Published: (2010-10-01)

Peripheral capillary non-perfusion in asymptomatic Waldenström's macroglobulinemia
by: Papaconstantinou Dimitris, et al.
Published: (2010-12-01)

Vitreous haemorrhage as the first presentation of undiagnosed Waldenstrom macroglobulinemia
by: Christina S Lim, et al.
Published: (2021-10-01)